Listed

Eledon Pharmaceuticals, Inc.: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 4, 2016 and accepted by EDGAR at Aug 4, 2016, 17:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$0us-gaap:SalesRevenueGoodsNet
Revenue6 months2016-01-01 to 2016-06-30$0us-gaap:SalesRevenueGoodsNet
Research and development3 months2016-04-01 to 2016-06-30$9.9mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-01-01 to 2016-06-30$17.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-04-01 to 2016-06-30−$13.6mus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$25.1mus-gaap:OperatingIncomeLoss
Income tax6 months2016-01-01 to 2016-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-04-01 to 2016-06-30−$13.5mus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$25.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$0.60us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$1.10us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2016-01-01 to 2016-06-30−$20.0mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2016-01-01 to 2016-06-30$17.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-06-30$12.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$46.2mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$46.9mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$7.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$8.0mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$38.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-16-672054. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.